Patent US4704102A successfully refreshed from Google Patents.
US4704102A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of eliminating intra abdominal infections
Assignee: Geneco Inc
•
Filing: 1986-02-27
•
Granted: 1987-11-03
•
Expires: 2006-02-27
Abstract
Abstract A method of irrigation of a body cavity, promoting asepsis, in which an irrigant solution, preferably a solution of iodine, is introduced into an abdominal cavity, retained within the abdominal cavity until asepsis is achieved, and drained from the abdominal cavity. Preferably, the solution includes a local anesthetic and a binding agent such as glycol. A catheter apparatus particularly adapted for implementation of the irrigation method comprises a drainage means and an independent irrigation means. In the catheter, a first valve assembly is connected to the drainage means so that the drainage of fluid from the abdominal cavity may be selectively regulated. A second valve assembly provides for selective opening of the irrigation means to allow introduction of the irrigation solution into the abdominal cavity. A kit comprising the catheter apparatus and auxiliary equipment, including a reservoir for the irrigant, a valve actuator tool and a syringe for use with a catheter retention means, provides for implementation of the treatment method.
Inventors
- 👤 B. Eugene Guthery
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 11:11
CPC Classifications
A; A61; A61M; A61M3/00; A61M3/02; A61M3/0279; A61M3/0283; A61M1/00; A61M1/71; A61M1/77; A61M25/00; A61M25/10; A61M25/1025
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
81 words
A method of promoting asepsis of a living human urinary bladder; said method comprising the steps of: (a) introducing an antiseptic solution into said bladder; (i) said antiseptic solution being a solution having a concentration of iodine ranging from approximately 0.0002% to 7% by weight; (ii) said solution further including glycol in a range from approximately 1% to 40% by weight; (b) retaining said antiseptic solution within said bladder until asepsis occurs; and, (c) draining said antiseptic solution from said bladder.
Claim 2
Independent Claim
81 words
A method of promoting asepsis of a living human urinary bladder; said method comprising the steps of: (a) introducing an antiseptic solution into said bladder; (i) said antiseptic solution being a solution having a concentration of iodine ranging from approximately 0.0002% to 7% by weight; (ii) said solution further including glycol in a range from approximately 1% to 40% by weight; (b) retaining said antiseptic solution within said bladder until asepsis occurs; and, (c) draining said antiseptic solution from said bladder.
Claim 3
Dependent Claim
20 words
The method according to claim 1 wherein: (a) said glycol is present in a concentration of about 20% by weight.
Claim 4
Dependent Claim
22 words
The method as set forth in claim 1 wherein: (a) said solution contains pyridium in a concentration of about 1% by weight.
Claim 5
Dependent Claim
20 words
The method according to claim 1 wherein: (a) said glycol is present in a concentration of about 20% by weight.
Claim 6
Independent Claim
95 words
A method of promoting asepsis of a living human urinary bladder; said method comprising the steps of: (a) introducing an antiseptic solution into said bladder; (i) said antiseptic solution being a dilution of Lugol's solution having a concentration of iodine ranging from approximately 0.0002% to 7% by weight; said Lugol's solution is substantially the only source of iodine in said solution; said solution includes glycol in a range of from approximately 1% to 40% by weight; (b) retaining said antiseptic solution within said bladder until asepsis occurs; (c) draining said antiseptic solution from said bladder.
Claim 7
Independent Claim
95 words
A method of promoting asepsis of a living human urinary bladder; said method comprising the steps of: (a) introducing an antiseptic solution into said bladder; (i) said antiseptic solution being a dilution of Lugol's solution having a concentration of iodine ranging from approximately 0.0002% to 7% by weight; said Lugol's solution is substantially the only source of iodine in said solution; said solution includes glycol in a range of from approximately 1% to 40% by weight; (b) retaining said antiseptic solution within said bladder until asepsis occurs; (c) draining said antiseptic solution from said bladder.
Claim 8
Independent Claim
93 words
A method of promoting asepsis of a living human urinary bladder; said method comprising the steps of: (a) introducing an antiseptic solution into said bladder; (i) said antiseptic solution being a dilution of Lugol's solution having a concentration of iodine ranging from approximately 0.0002% to 7% by weight; said Lugol's solution is substantially the only source of iodine in said solution; said solution contains pyridium in a concentration of about 1% by weight; (b) retaining said antiseptic solution within said bladder until asepsis occurs; and (c) draining said antiseptic solution from said bladder.
Claim 9
Independent Claim
93 words
A method of promoting asepsis of a living human urinary bladder; said method comprising the steps of: (a) introducing an antiseptic solution into said bladder; (i) said antiseptic solution being a dilution of Lugol's solution having a concentration of iodine ranging from approximately 0.0002% to 7% by weight; said Lugol's solution is substantially the only source of iodine in said solution; said solution contains pyridium in a concentration of about 1% by weight; (b) retaining said antiseptic solution within said bladder until asepsis occurs; and (c) draining said antiseptic solution from said bladder.
References Cited (Backward Citations)
US2927058A
Cited
US3233609A
Cited
US3583404A
Cited
US3981299A
Cited
US3911107A
Cited
US3823714A
Cited
US4351333A
Cited
US4235230A
Cited
US4271149A
Cited
US4271149B1
Cited
US4402937A
Cited
US4539234A
Cited
US4419094A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-11-02 | 1991-05-04 | 1991-11-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-11-02 | 1995-05-04 | 1995-11-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-11-02 | 1999-05-04 | 1999-11-03 | $7700.00 | Window Closed / Lapsed |